CXCL10, Human, ELISA Kit, RayBio <IP-10, ELISA Kit>

データシート

• 商品コード：ELH-IP10-1
• メーカー：RAY
• 包装：1kit
• 価格： ¥108,000
• 在庫：無(未発注)

マイリストに追加 マイリストに追加済

• No.： 1
• 文献情報：
  Hardy GAD, Sieg S, Rodriguez B, et al. Interferon-留 is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PLoS ONE. 2013;8(2):e56527.
  
  
• 備考：
  Species: Human, Sample Type: Plasma
• 参照：
  

• No.： 2
• 文献情報：
  Fujiwara S et al. Interleukin (IL)-17 versus IL-27: opposite effects on tumor necrosis factor-&#x3B1;-mediated chemokine production in human keratinocytes. Exp. Dermatol. 2012 Jan;21(1):70-2
  Fujiwara S et al
  2012/01/01
  
• 備考：
  Species: Human, Sample Type: Conditioned Media
• 参照：
  

• No.： 3
• 文献情報：
  Wu C et al. Clinical symptoms, immune factors, and molecular characteristics of an adult male in Shenzhen, China infected with influenza virus H5N1. J. Med. Virol. 2013 May;85(5):760-8
  Wu C et al
  2013/01/01
  
• 備考：
  Species: Human, Sample Type: Serum
• 参照：
  

• No.： 4
• 文献情報：
  Ko TM et al. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease. Circ. Res. 2015 Feb;116(5):876-83
  Ko TM et al
  2015/01/01
  
• 備考：
  Species: Human, Sample Type: Plasma
• 参照：
  

• No.： 5
• 文献情報：
  Gunluoglu G et al. Diagnosing latent tuberculosis in immunocompromised patients measuring blood IP-10 production capacity: an analysis of chronic renal failure patients. Intern. Med. 2015;54(5):465-72
  Gunluoglu G et al
  2015/01/01
  
• 備考：
  Species: Human, Sample Type: Plasma
• 参照：
  

• No.： 6
• 文献情報：
  Marozin S et al. STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma. Cancer Gene Ther. 2015 Jun;22(6):317-25
  Marozin S et al
  2015/01/01
  
• 備考：
  Species: Human, Sample Type: Conditioned Media
• 参照：
  

• No.： 7
• 文献情報：
  Vargas-Inchaustegui D., Hogg A., Tulliano G., et al.CXCL10 Production by Human Monocytes in Response to Leishmania braziliensis Infection. Infect. Immun. January 2010 vol. 78 no. 1 301-308
  
  
• 備考：
  
• 参照：
  

• No.： 8
• 文献情報：
  Hardy GAD, Sieg S, Rodriguez B, et al. Interferon-留 is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers. PLoS ONE. 2013;8(2):e56527.
  
  
• 備考：
  
• 参照：
  

• No.： 9
• 文献情報：
  Abdel Fattah H., Sadek Sabbour G., Hamed A., et al. INTERFERON-GAMMA INDUCIBLE PROTEIN 10 (CXCL 10) AS A PREDICTOR OF LIVER FIBROSIS IN CHRONIC LIVER DISEASE. AAMJ, Vol. 10, N. 3, Sep, 2012, Suppl.
  
  
• 備考：
  
• 参照：
  

• No.： 10
• 文献情報：
  Kine E., Trine B., Alexander H., et al. Peripheral Blood Cells from Patients with Autoimmune Addison&#39;s Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines. J Interferon Cytokine Res. 2015 Oct;35
  Edvardsen K et al
  2015/01/01
  
• 備考：
  
• 参照：
  

• No.： 11
• 文献情報：
  Perisdsky Y., Hill J., Zhang M., et al. Dysfunction of brain pericytes in chronic neuroinflammation. J Cereb Blood Flow Metab. 2016 Apr;36(4):794-807. doi: 10.1177/0271678X15606149.
  Persidsky Y et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 12
• 文献情報：
  Spaks A., Jaunalksne I., Spaka I., et al. Diagnostic Value of Circulating CXC Chemokines in Non-small Cell Lung Cancer. Anticancer Res. 2015 Dec;35(12):6979-83.
  Spaks A et al
  2015/01/01
  
• 備考：
  
• 参照：
  

• No.： 13
• 文献情報：
  Gao Q., Camous X., Lu Y., et al. Novel inflammatory markers associated with cognitive performance: Singapore Longitudinal Ageing Studies. Neurobiol Aging. 2016 Mar;39:140-6. doi: 10.1016/j.neurobiolaging.2015.12.002.
  Gao Q et al
  2016/01/01
  
• 備考：
  
• 参照：
  

• No.： 14
• 文献情報：
  Cakir, Mehtap, et al. &quot;Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases.&quot; Autoimmunity 44.6 (2011): 496-503.
  Cakir M et al
  2011/01/01
  
• 備考：
  
• 参照：
  

• No.： 15
• 文献情報：
  Bratland, Eirik, Alexander Hellesen, and Eystein S. Husebye. &quot;Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3.&quot; Molecular and cellular endocrinology 365.1 (2013): 75-83.
  Bratland E et al
  2013/01/01
  
• 備考：
  
• 参照：
  

• No.： 16
• 文献情報：
  Marozin S., Altonmonte J., Munoz-Alvarez K., et al. STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma. Cancer Gene Ther. 2015 Jun;22(6):317-25. doi: 10.1038/cgt.2015.
  
  
• 備考：
  species: Human, sample_type: Conditioned Media (Carcinoma Cell lines treated with a Stat3 inhibitor or control)
• 参照：
  

• No.： 17
• 文献情報：
  Fujiwara S., Nagai H., Oniki S., et al. Interleukin (IL)-17 versus IL-27: opposite effects on tumor necrosis factor-?-mediated chemokine production in human keratinocytes. Exp Dermatol. 2012 Jan;21(1):70-2. doi: 10.1111/j.1600-0625.2011.01384.x
  
  
• 備考：
  species: Human, sample_type: Conditioned Media (Normal human epidermal keratinocytes)
• 参照：
  

• No.： 18
• 文献情報：
  Ko TM., Kuo HC., Chang JS., et al. CXCL10/IP-10 is a Biomarker and Mediator for Kawasaki Disease. Circ Res. 2015 Feb 27;116(5):876-83. doi: 10.1161/CIRCRESAHA.116.305834.
  
  
• 備考：
  species: Human, sample_type: Plasma (Kawasaki&#39;s Disease patients)
• 参照：
  

• No.： 19
• 文献情報：
  Wu C, Lu X, Wang X, et al. Clinical symptoms, immune factors, and molecular characteristics of an adult male in Shenzhen, China infected with influenza virus H5N1. J Med Virol. 2013 May;85(5):760-768.
  
  
• 備考：
  species: Human, sample_type: Serum
• 参照：